Fred Alger Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
143,413
+77,983
| +119% | +$903K | 0.01% | 323 |
|
|
2025
Q1 | $571K | Hold |
65,430
| – | – | ﹤0.01% | 349 |
|
|
2024
Q4 | $940K | Sell |
65,430
-42
| -0.1% | -$603 | ﹤0.01% | 366 |
|
|
2024
Q3 | $1.48M | Sell |
65,472
-501
| -0.8% | -$11.3K | 0.01% | 341 |
|
|
2024
Q2 | $1.28M | Sell |
65,973
-379,594
| -85% | -$7.38M | 0.01% | 347 |
|
|
2024
Q1 | $16.7M | Buy |
445,567
+40,384
| +10% | +$1.52M | 0.08% | 162 |
|
|
2023
Q4 | $22.7M | Buy |
+405,183
| New | +$22.7M | 0.12% | 133 |
|
|
2023
Q2 | – | Sell |
-8,820
| Closed | -$492K | – | 572 |
|
|
2023
Q1 | $492K | Buy |
+8,820
| New | +$492K | ﹤0.01% | 402 |
|
|
2022
Q2 | – | Sell |
-328,561
| Closed | -$25M | – | 549 |
|
|
2022
Q1 | $25M | Buy |
328,561
+248,537
| +311% | +$18.9M | 0.08% | 174 |
|
|
2021
Q4 | $11.9M | Sell |
80,024
-76,023
| -49% | -$11.3M | 0.03% | 232 |
|
|
2021
Q3 | $22.7M | Buy |
156,047
+16,610
| +12% | +$2.42M | 0.05% | 196 |
|
|
2021
Q2 | $27.3M | Sell |
139,437
-27,875
| -17% | -$5.46M | 0.06% | 195 |
|
|
2021
Q1 | $30.3M | Buy |
167,312
+106,728
| +176% | +$19.3M | 0.08% | 187 |
|
|
2020
Q4 | $8.58M | Buy |
60,584
+27,046
| +81% | +$3.83M | 0.02% | 244 |
|
|
2020
Q3 | $4.18M | Buy |
33,538
+9,123
| +37% | +$1.14M | 0.01% | 255 |
|
|
2020
Q2 | $2.18M | Sell |
24,415
-12,002
| -33% | -$1.07M | 0.01% | 300 |
|
|
2020
Q1 | $2.27M | Buy |
36,417
+1,714
| +5% | +$107K | 0.01% | 262 |
|
|
2019
Q4 | $2.65M | Buy |
34,703
+28,703
| +478% | +$2.19M | 0.01% | 278 |
|
|
2019
Q3 | $302K | Buy |
+6,000
| New | +$302K | ﹤0.01% | 391 |
|